Related Experiment Video
Updated: Jul 13, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nucleoside and nucleotide reverse transcriptase inhibitors in children
Carlo Giaquinto1, Osvalda Rampon, Martina Penazzato
1Department of Pediatrics, Università di Padova, Padova, Italy. carlog@pediatria.unipd.it
Antiretroviral therapy (ART) for children with HIV is challenging due to formulation and drug availability issues. Nucleoside reverse transcriptase inhibitors (NRTIs) are crucial, but optimized pediatric use requires better fixed-dose combinations and research.
Area of Science:
- Pediatric infectious diseases
- Pharmacology
- HIV/AIDS treatment
Background:
- Millions of children globally live with HIV, yet access to appropriate antiretroviral therapy (ART) remains limited.
- Pediatric ART faces challenges including lack of pediatric drug formulations, limited drug options, and unique toxicity concerns.
Purpose of the Study:
- To review available information on nucleoside reverse transcriptase inhibitors (NRTIs) for HIV-infected children.
- To guide the selection of optimal NRTI backbones for combination ART in pediatric populations.
Main Methods:
- Review of existing literature on NRTI use in pediatric HIV treatment.
- Analysis of NRTI drug properties, formulations, and guideline recommendations for children.
Main Results:
- Nucleoside reverse transcriptase inhibitors (NRTIs) are a cornerstone of pediatric ART, with more licensed drugs and formulations compared to other classes.
- Standard NRTI backbones involve cytidine and thymidine analogues, with triple NRTI therapy recommended for adherence challenges.
Conclusions:
- Increasing ART access for children is critical, but drug selection is hampered by a lack of pediatric-specific formulations and data.
- Further research and fixed-dose combinations are needed to optimize NRTI use in pediatric HIV treatment.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
Pharmacokinetics in Pediatric Patients: Drug Excretion
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes

